AU2008277251A1 - Diagnosis and treatment of varicocele and prostate disorders - Google Patents
Diagnosis and treatment of varicocele and prostate disorders Download PDFInfo
- Publication number
- AU2008277251A1 AU2008277251A1 AU2008277251A AU2008277251A AU2008277251A1 AU 2008277251 A1 AU2008277251 A1 AU 2008277251A1 AU 2008277251 A AU2008277251 A AU 2008277251A AU 2008277251 A AU2008277251 A AU 2008277251A AU 2008277251 A1 AU2008277251 A1 AU 2008277251A1
- Authority
- AU
- Australia
- Prior art keywords
- vein
- catheter
- wire
- prostate
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 201000004822 varicocele Diseases 0.000 title claims description 57
- 238000011282 treatment Methods 0.000 title claims description 41
- 238000003745 diagnosis Methods 0.000 title description 23
- 208000017497 prostate disease Diseases 0.000 title description 4
- 210000003462 vein Anatomy 0.000 claims description 195
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 claims description 184
- 210000002307 prostate Anatomy 0.000 claims description 108
- 229960003604 testosterone Drugs 0.000 claims description 92
- 238000000034 method Methods 0.000 claims description 76
- 210000004369 blood Anatomy 0.000 claims description 73
- 239000008280 blood Substances 0.000 claims description 73
- 238000010992 reflux Methods 0.000 claims description 46
- 239000000463 material Substances 0.000 claims description 45
- 239000003229 sclerosing agent Substances 0.000 claims description 33
- 206010060862 Prostate cancer Diseases 0.000 claims description 25
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 25
- 230000002706 hydrostatic effect Effects 0.000 claims description 22
- 230000000694 effects Effects 0.000 claims description 19
- 238000005259 measurement Methods 0.000 claims description 16
- 230000010102 embolization Effects 0.000 claims description 15
- 238000004519 manufacturing process Methods 0.000 claims description 15
- 239000003814 drug Substances 0.000 claims description 14
- 230000007257 malfunction Effects 0.000 claims description 14
- 230000002146 bilateral effect Effects 0.000 claims description 12
- 210000004204 blood vessel Anatomy 0.000 claims description 11
- 208000024891 symptom Diseases 0.000 claims description 11
- 230000002792 vascular Effects 0.000 claims description 11
- 210000002073 venous valve Anatomy 0.000 claims description 11
- 206010020880 Hypertrophy Diseases 0.000 claims description 9
- 208000034189 Sclerosis Diseases 0.000 claims description 9
- 208000007536 Thrombosis Diseases 0.000 claims description 9
- 230000005855 radiation Effects 0.000 claims description 9
- 238000002679 ablation Methods 0.000 claims description 8
- 230000017531 blood circulation Effects 0.000 claims description 8
- 208000021267 infertility disease Diseases 0.000 claims description 8
- 230000032683 aging Effects 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 7
- 239000003292 glue Substances 0.000 claims description 7
- 230000003247 decreasing effect Effects 0.000 claims description 6
- 238000002560 therapeutic procedure Methods 0.000 claims description 6
- 201000002282 venous insufficiency Diseases 0.000 claims description 6
- 206010020718 hyperplasia Diseases 0.000 claims description 4
- 238000011144 upstream manufacturing Methods 0.000 claims description 4
- 239000012781 shape memory material Substances 0.000 claims description 3
- 230000005684 electric field Effects 0.000 claims description 2
- 239000004568 cement Substances 0.000 claims 1
- 210000004013 groin Anatomy 0.000 claims 1
- 210000001550 testis Anatomy 0.000 description 35
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 28
- 238000012360 testing method Methods 0.000 description 24
- 230000002381 testicular Effects 0.000 description 21
- 206010028980 Neoplasm Diseases 0.000 description 16
- 201000011510 cancer Diseases 0.000 description 15
- 210000002966 serum Anatomy 0.000 description 15
- 230000007246 mechanism Effects 0.000 description 14
- 230000002829 reductive effect Effects 0.000 description 14
- 238000002604 ultrasonography Methods 0.000 description 14
- 230000000903 blocking effect Effects 0.000 description 12
- 238000002347 injection Methods 0.000 description 12
- 239000007924 injection Substances 0.000 description 12
- 241000282414 Homo sapiens Species 0.000 description 9
- 230000001771 impaired effect Effects 0.000 description 9
- 206010029446 nocturia Diseases 0.000 description 8
- 238000007632 sclerotherapy Methods 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 210000001631 vena cava inferior Anatomy 0.000 description 8
- 206010027476 Metastases Diseases 0.000 description 7
- 230000004089 microcirculation Effects 0.000 description 7
- 206010021143 Hypoxia Diseases 0.000 description 6
- 208000007466 Male Infertility Diseases 0.000 description 6
- 239000002872 contrast media Substances 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000035558 fertility Effects 0.000 description 6
- 230000007954 hypoxia Effects 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 239000000051 antiandrogen Substances 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 238000003384 imaging method Methods 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 238000002559 palpation Methods 0.000 description 5
- 210000002796 renal vein Anatomy 0.000 description 5
- 238000001931 thermography Methods 0.000 description 5
- 210000003484 anatomy Anatomy 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 210000003191 femoral vein Anatomy 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000002280 anti-androgenic effect Effects 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 230000003190 augmentative effect Effects 0.000 description 3
- 238000001574 biopsy Methods 0.000 description 3
- RSIHSRDYCUFFLA-DYKIIFRCSA-N boldenone Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 RSIHSRDYCUFFLA-DYKIIFRCSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- RSIHSRDYCUFFLA-UHFFFAOYSA-N dehydrotestosterone Natural products O=C1C=CC2(C)C3CCC(C)(C(CC4)O)C4C3CCC2=C1 RSIHSRDYCUFFLA-UHFFFAOYSA-N 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- JJJFUHOGVZWXNQ-UHFFFAOYSA-N enbucrilate Chemical group CCCCOC(=O)C(=C)C#N JJJFUHOGVZWXNQ-UHFFFAOYSA-N 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 210000003111 iliac vein Anatomy 0.000 description 3
- 208000000509 infertility Diseases 0.000 description 3
- 230000036512 infertility Effects 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- 238000002406 microsurgery Methods 0.000 description 3
- 238000009931 pascalization Methods 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 230000003679 aging effect Effects 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 239000003098 androgen Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000003412 degenerative effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000002059 diagnostic imaging Methods 0.000 description 2
- 230000010339 dilation Effects 0.000 description 2
- 229950010048 enbucrilate Drugs 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000009126 molecular therapy Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000005267 prostate cell Anatomy 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 230000008320 venous blood flow Effects 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- 206010002261 Androgen deficiency Diseases 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 108700012941 GNRH1 Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 1
- 108010069236 Goserelin Proteins 0.000 description 1
- BLCLNMBMMGCOAS-URPVMXJPSA-N Goserelin Chemical compound C([C@@H](C(=O)N[C@H](COC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NNC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 BLCLNMBMMGCOAS-URPVMXJPSA-N 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 102100035593 POU domain, class 2, transcription factor 1 Human genes 0.000 description 1
- 101710084414 POU domain, class 2, transcription factor 1 Proteins 0.000 description 1
- 208000000450 Pelvic Pain Diseases 0.000 description 1
- 208000025844 Prostatic disease Diseases 0.000 description 1
- 206010051482 Prostatomegaly Diseases 0.000 description 1
- BNRNXUUZRGQAQC-UHFFFAOYSA-N Sildenafil Natural products CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000004830 Super Glue Substances 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 238000011374 additional therapy Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003872 anastomosis Effects 0.000 description 1
- 102000001307 androgen receptors Human genes 0.000 description 1
- 108010080146 androgen receptors Proteins 0.000 description 1
- 230000001548 androgenic effect Effects 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003509 anti-fertility effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 230000007196 blood circulation pathway Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000005206 flow analysis Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- XLXSAKCOAKORKW-UHFFFAOYSA-N gonadorelin Chemical class C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 XLXSAKCOAKORKW-UHFFFAOYSA-N 0.000 description 1
- 229960002913 goserelin Drugs 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 210000000494 inguinal canal Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002697 interventional radiology Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002357 laparoscopic surgery Methods 0.000 description 1
- 238000004093 laser heating Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 210000001363 mesenteric artery superior Anatomy 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- HKWLCBGLVAWZRK-CBYCSKBWSA-N methyl (3s,5r,8r,9s,10s,13r,14s,17s)-14-amino-10,13-dimethyl-3-[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-17-carboxylate Chemical compound O([C@@H]1C[C@H]2CC[C@H]3[C@@]4(N)CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)C(=O)OC)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O HKWLCBGLVAWZRK-CBYCSKBWSA-N 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 229940083820 other sclerosing agent in atc Drugs 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 201000005825 prostate adenocarcinoma Diseases 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011555 rabbit model Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002784 sclerotic effect Effects 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 210000002863 seminiferous tubule Anatomy 0.000 description 1
- DEIYFTQMQPDXOT-UHFFFAOYSA-N sildenafil citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 DEIYFTQMQPDXOT-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960000776 sodium tetradecyl sulfate Drugs 0.000 description 1
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008337 systemic blood flow Effects 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 239000003106 tissue adhesive Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 208000024470 urgency of urination Diseases 0.000 description 1
- 210000000685 uterine artery Anatomy 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 230000009724 venous congestion Effects 0.000 description 1
- 229940094720 viagra Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
- A61M25/007—Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/09—Guide wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
- A61M29/02—Dilators made of swellable material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B18/24—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/09—Guide wires
- A61M2025/09175—Guide wires having specific characteristics at the distal tip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/09—Guide wires
- A61M2025/09175—Guide wires having specific characteristics at the distal tip
- A61M2025/09183—Guide wires having specific characteristics at the distal tip having tools at the distal tip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1095—Balloon catheters with special features or adapted for special applications with perfusion means for enabling blood circulation while the balloon is in an inflated state or in a deflated state, e.g. permanent by-pass within catheter shaft
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicines Containing Plant Substances (AREA)
- Surgical Instruments (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/826,283 | 2007-07-13 | ||
| US11/826,283 US20090018486A1 (en) | 2007-07-13 | 2007-07-13 | Diagnosis and treatment of vericocele and prostate disorders |
| US6451108P | 2008-03-10 | 2008-03-10 | |
| US61/064,511 | 2008-03-10 | ||
| PCT/IL2008/000971 WO2009010962A2 (en) | 2007-07-13 | 2008-07-13 | Diagnosis and treatment of varicocele and prostate disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2008277251A1 true AU2008277251A1 (en) | 2009-01-22 |
Family
ID=40260179
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2008277251A Abandoned AU2008277251A1 (en) | 2007-07-13 | 2008-07-13 | Diagnosis and treatment of varicocele and prostate disorders |
| AU2008277252A Abandoned AU2008277252A1 (en) | 2007-07-13 | 2008-07-13 | Methods and apparatuses for vascular and prostate treatment |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2008277252A Abandoned AU2008277252A1 (en) | 2007-07-13 | 2008-07-13 | Methods and apparatuses for vascular and prostate treatment |
Country Status (6)
| Country | Link |
|---|---|
| EP (2) | EP2170180A4 (enExample) |
| JP (1) | JP2010533052A (enExample) |
| CN (1) | CN101801289A (enExample) |
| AU (2) | AU2008277251A1 (enExample) |
| CA (3) | CA2693225A1 (enExample) |
| WO (3) | WO2009010963A2 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1841368B1 (en) * | 2005-01-25 | 2015-06-10 | Covidien LP | Structures for permanent occlusion of a hollow anatomical structure |
| CA2793561A1 (en) | 2010-03-06 | 2011-09-15 | Nfusion Vascular Systems, Llc | Recovery catheter assembly |
| US9108029B2 (en) | 2012-05-21 | 2015-08-18 | Nfusion Vascular Systems, Llc | Recovery catheter assembly and method |
| CN108742951B (zh) | 2012-06-06 | 2021-05-25 | 洋红医疗有限公司 | 人工肾脏瓣膜 |
| CA3126978C (en) | 2013-03-13 | 2025-02-06 | Magenta Medical Ltd. | TURBINE TO BE USED WITH AN AXIAL SUPPORT ELEMENT |
| US10583231B2 (en) | 2013-03-13 | 2020-03-10 | Magenta Medical Ltd. | Blood pump |
| RU2525219C1 (ru) * | 2013-04-02 | 2014-08-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Тверская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Способ ретроградной склеротерапии варикоцеле при брыжеечно-яичковых анастамозах |
| US9764113B2 (en) | 2013-12-11 | 2017-09-19 | Magenta Medical Ltd | Curved catheter |
| WO2015100393A1 (en) * | 2013-12-27 | 2015-07-02 | Renalpro Medical, Inc. | Devices and methods for treating acute kidney injury |
| RU2572553C1 (ru) * | 2014-08-01 | 2016-01-20 | Леонид Зиновьевич Вельшер | Способ лечения рака предстательной железы |
| US11291824B2 (en) | 2015-05-18 | 2022-04-05 | Magenta Medical Ltd. | Blood pump |
| WO2017040484A1 (en) * | 2015-08-31 | 2017-03-09 | Gentuity, Llc | Imaging system includes imaging probe and delivery devices |
| US11039915B2 (en) | 2016-09-29 | 2021-06-22 | Magenta Medical Ltd. | Blood vessel tube |
| EP3556409B1 (en) | 2016-10-25 | 2022-01-05 | Magenta Medical Ltd. | Ventricular assist device |
| US11033727B2 (en) | 2016-11-23 | 2021-06-15 | Magenta Medical Ltd. | Blood pumps |
| EP3700406A4 (en) | 2017-11-28 | 2021-12-29 | Gentuity LLC | Imaging system |
| US10905808B2 (en) | 2018-01-10 | 2021-02-02 | Magenta Medical Ltd. | Drive cable for use with a blood pump |
| CN111556764B (zh) | 2018-01-10 | 2023-07-07 | 马真塔医药有限公司 | 心室辅助装置 |
| CN108158654B (zh) * | 2018-01-12 | 2020-06-12 | 郑州大学第一附属医院 | 一种便携式磁感应定位导向装置及其方法 |
| US10893927B2 (en) | 2018-03-29 | 2021-01-19 | Magenta Medical Ltd. | Inferior vena cava blood-flow implant |
| WO2020061001A1 (en) | 2018-09-17 | 2020-03-26 | Gentuity, Llc | Imaging system with optical pathway |
| EP3782665B1 (en) | 2019-01-24 | 2021-08-25 | Magenta Medical Ltd. | Ventricular assist device |
| CN114040702A (zh) | 2019-04-30 | 2022-02-11 | Gentuity有限责任公司 | 具有流体加压元件的成像探头 |
| US12239412B2 (en) | 2019-05-21 | 2025-03-04 | Spryte Medical, Inc. | Systems and methods for OCT-guided treatment of a patient |
| AU2020277752B2 (en) | 2019-05-23 | 2025-03-06 | Magenta Medical Ltd | Blood pumps |
| RU2729431C1 (ru) * | 2019-12-27 | 2020-08-06 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Тихоокеанский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ лапароскопического лечения варикоцеле |
| CA3176272A1 (en) | 2020-04-07 | 2021-10-14 | Magenta Medical Ltd | Ventricular assist device |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4714460A (en) * | 1983-07-29 | 1987-12-22 | Reynaldo Calderon | Methods and systems for retrograde perfusion in the body for curing it of the disease or immume deficiency |
| CH668192A5 (de) * | 1985-11-29 | 1988-12-15 | Schneider Medintag Ag | Katheter zur behandlung von verengten stellen, beispielsweise in einem blutgefaess. |
| US4762128A (en) * | 1986-12-09 | 1988-08-09 | Advanced Surgical Intervention, Inc. | Method and apparatus for treating hypertrophy of the prostate gland |
| ATE121954T1 (de) * | 1988-08-24 | 1995-05-15 | Marvin J Slepian | Endoluminale dichtung mit bisdegradierbaren polymeren. |
| FR2639237B1 (fr) * | 1988-11-23 | 1997-10-31 | Boussignac Georges | Catheter destine a etre introduit dans un canal corporel |
| CN2086610U (zh) * | 1991-03-05 | 1991-10-16 | 陆秉仁 | 双囊式前列腺尿道扩张装置 |
| US5529574A (en) * | 1992-08-21 | 1996-06-25 | Frackelton; James P. | Method and apparatus for treatment of the prostate |
| AU2255195A (en) * | 1994-04-06 | 1995-10-30 | William Cook Europe A/S | A medical article for implantation into the vascular system of a patient |
| US5779673A (en) * | 1995-06-26 | 1998-07-14 | Focal, Inc. | Devices and methods for application of intraluminal photopolymerized gels |
| US5780435A (en) * | 1995-12-15 | 1998-07-14 | Praecis Pharmaceuticals Incorporated | Methods for treating prostate cancer with LHRH-R antagonists |
| US5989230A (en) * | 1996-01-11 | 1999-11-23 | Essex Technology, Inc. | Rotate to advance catheterization system |
| US6200312B1 (en) * | 1997-09-11 | 2001-03-13 | Vnus Medical Technologies, Inc. | Expandable vein ligator catheter having multiple electrode leads |
| US5947985A (en) * | 1997-11-12 | 1999-09-07 | Imran; Mir A. | Apparatus and method for cleaning diseased vein grafts |
| US6319251B1 (en) * | 1998-09-24 | 2001-11-20 | Hosheng Tu | Medical device and methods for treating intravascular restenosis |
| US6036689A (en) * | 1998-09-24 | 2000-03-14 | Tu; Lily Chen | Ablation device for treating atherosclerotic tissues |
| US6673352B1 (en) * | 1999-09-14 | 2004-01-06 | The General Hospital Corporation | Use of Mullerian inhibiting substance for treating excess androgen states |
| US6575932B1 (en) * | 1999-12-02 | 2003-06-10 | Ottawa Heart Institute | Adjustable multi-balloon local delivery device |
| ATE357878T1 (de) * | 1999-12-22 | 2007-04-15 | Boston Scient Ltd | Endoluminaler okklusions-spülkatheter |
| AUPQ641400A0 (en) * | 2000-03-23 | 2000-04-15 | Kleiner, Daniel E. | A device incorporating a hollow member for being positioned along a body cavity of a patient and method of positioning same |
| US20050107738A1 (en) * | 2000-07-21 | 2005-05-19 | Slater Charles R. | Occludable intravascular catheter for drug delivery and method of using the same |
| GB2369996B (en) * | 2000-12-18 | 2004-06-23 | S T D Pharmaceutical Products | Method and apparatus for producing an injectable foam |
| US6710037B2 (en) * | 2001-05-01 | 2004-03-23 | Schering Corporation | Method of treating androgen-dependent disorders |
| US7169161B2 (en) * | 2001-11-06 | 2007-01-30 | Possis Medical, Inc. | Guidewire having occlusive device and repeatably crimpable proximal end |
| DE50309201D1 (de) * | 2002-03-09 | 2008-04-03 | Jens P Brodersen | Sklerosierungskatheter zur sklerosierung von blutgefässen insbesondere venen |
| US7077801B2 (en) * | 2003-02-19 | 2006-07-18 | Corlife Gbr | Methods and devices for improving cardiac output |
| US20040180855A1 (en) * | 2003-02-19 | 2004-09-16 | Schumacher William A. | Methods of treating thrombosis with reduced risk of increased bleeding times |
| EP1527743B1 (de) * | 2003-10-29 | 2009-07-29 | Celon AG Medical Instruments | Medizingerät für die Elektrotomie |
| US20050182342A1 (en) * | 2004-02-13 | 2005-08-18 | Medtronic, Inc. | Monitoring fluid flow in the gastrointestinal tract |
| US7824408B2 (en) * | 2004-08-05 | 2010-11-02 | Tyco Healthcare Group, Lp | Methods and apparatus for coagulating and/or constricting hollow anatomical structures |
| US20060079923A1 (en) * | 2004-08-09 | 2006-04-13 | Manik Chhabra | Aneurysm treatment using semi-compliant balloon |
| CA2574429A1 (en) * | 2004-08-19 | 2006-03-02 | Veinrx, Inc. | An occludable intravascular catheter for drug delivery and method of using the same |
| US7402320B2 (en) * | 2004-08-31 | 2008-07-22 | Vnus Medical Technologies, Inc. | Apparatus, material compositions, and methods for permanent occlusion of a hollow anatomical structure |
| US20060159767A1 (en) * | 2004-12-22 | 2006-07-20 | Elan Pharma International Limited | Nanoparticulate bicalutamide formulations |
| EP1841368B1 (en) * | 2005-01-25 | 2015-06-10 | Covidien LP | Structures for permanent occlusion of a hollow anatomical structure |
| JP2008173137A (ja) * | 2005-03-03 | 2008-07-31 | Goodman Co Ltd | ダブルバルーンカテーテル |
| US20060204588A1 (en) * | 2005-03-10 | 2006-09-14 | Elan Pharma International Limited | Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof |
-
2008
- 2008-07-13 EP EP08776607A patent/EP2170180A4/en not_active Withdrawn
- 2008-07-13 WO PCT/IL2008/000972 patent/WO2009010963A2/en not_active Ceased
- 2008-07-13 EP EP08776606A patent/EP2178594A4/en not_active Withdrawn
- 2008-07-13 WO PCT/IL2008/000971 patent/WO2009010962A2/en not_active Ceased
- 2008-07-13 CN CN200880106666A patent/CN101801289A/zh active Pending
- 2008-07-13 AU AU2008277251A patent/AU2008277251A1/en not_active Abandoned
- 2008-07-13 CA CA2693225A patent/CA2693225A1/en not_active Abandoned
- 2008-07-13 JP JP2010516646A patent/JP2010533052A/ja active Pending
- 2008-07-13 CA CA2693735A patent/CA2693735A1/en not_active Abandoned
- 2008-07-13 WO PCT/IL2008/000973 patent/WO2009010964A2/en not_active Ceased
- 2008-07-13 AU AU2008277252A patent/AU2008277252A1/en not_active Abandoned
- 2008-07-13 CA CA2693227A patent/CA2693227A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009010962A3 (en) | 2010-09-16 |
| WO2009010963A3 (en) | 2010-01-14 |
| EP2170180A4 (en) | 2011-02-23 |
| CN101801289A (zh) | 2010-08-11 |
| WO2009010964A2 (en) | 2009-01-22 |
| CA2693227A1 (en) | 2009-01-22 |
| EP2178594A4 (en) | 2011-02-23 |
| AU2008277252A1 (en) | 2009-01-22 |
| CA2693225A1 (en) | 2009-01-22 |
| EP2170180A2 (en) | 2010-04-07 |
| WO2009010964A3 (en) | 2010-02-25 |
| CA2693735A1 (en) | 2009-01-22 |
| WO2009010963A2 (en) | 2009-01-22 |
| WO2009010962A2 (en) | 2009-01-22 |
| EP2178594A2 (en) | 2010-04-28 |
| JP2010533052A (ja) | 2010-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2008277251A1 (en) | Diagnosis and treatment of varicocele and prostate disorders | |
| US20090018486A1 (en) | Diagnosis and treatment of vericocele and prostate disorders | |
| US20100286106A1 (en) | Methods and apparatus for treating the prostate | |
| US7766961B2 (en) | Systems and methods for performing bi-lateral interventions or diagnosis in branched body lumens | |
| JP2006508776A (ja) | 腎臓内カテーテルを介する選択的物質送達のための方法および装置 | |
| WO2009039017A1 (en) | Method and apparatus for conducting peripheral vascular disease procedures using a novel anchor balloon catheter | |
| WO2004107965A2 (en) | Systems and methods for performing bi-lateral interventions or diagnosis in branched body lumens | |
| Ascher et al. | Duplex-guided balloon angioplasty and stenting for femoropopliteal arterial occlusive disease: an alternative in patients with renal insufficiency | |
| Khashab et al. | Endoscopic ultrasonography as a therapeutic modality | |
| CN115379873B (zh) | 血管手术用的可偏转的锚定球囊导管 | |
| Jeong et al. | Percutaneous transhepatic choledochoscopic lithotomy as a rescue therapy for removal of bile duct stones in Billroth II gastrectomy patients who are difficult to perform ERCP | |
| US20100204639A1 (en) | Diagnosis and treatment of varicocele and prostate disorders | |
| IL203271A (en) | Prostate Treatment System | |
| Shoji et al. | Percutaneous Closure Based on Physiological Assessment of an Arteriovenous Fistula in a Patient With Chronic Limb Threatening Ischaemia | |
| RSE | Interventional radiology curriculum for medical students | |
| Zhu et al. | Interventional Treatment and Imaging Evaluation of Hepatobiliary Diseases | |
| Matsubara et al. | Interventional EUS for pancreatic cancer and cholangiocarcinoma | |
| Alexander et al. | Management of pancreaticobiliary disease: endoscopic retrograde cholangiopancreatography (ERCP) | |
| Navuluri et al. | Imaging and Radiologic Intervention in the Biliary Tract | |
| Ahuja et al. | Transazygous hemodialysis access in nutcracker syndrome | |
| Muniraj | Chronic Pancreatitis | |
| Nakai et al. | Report of the International Symposiums at the 95th Congress of Japan Gastroenterological Endoscopy Society in Tokyo, 2018. | |
| Cho | CO2 with Large-Needle TIPS | |
| McNulty | Interventional Radiology | |
| Cosgrove et al. | Endoscopic Drainage of Pancreatic Fluid Collections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |